M. Peter Marinkovich, MD, on Bringing RDEB Treatment to the Local Level With B-VEC
The associate professor of dermatology at Stanford University discussed how the May 2023 approval of B-VEC may shift the treatment field for RDEB.
M. Peter Marinkovich, MD, on Increased Accessibility With Topical B-VEC DEB Gene Therapy
The associate professor of dermatology at Stanford University discussed the potential impact of Vyjuvek’s approval in the derm field.
M. Peter Marinkovich, MD, on Developing B-VEC, First Approved Derm Gene Therapy
The associate professor of dermatology at Stanford University discussed his experiences investigating and helping to develop Vyjuvek, approved for treating DEB.